A Novel Mutation of the Calcium Sensing Receptor Gene in a Franconian Kindred: Heterozygous Mutation c.1697_1698delTG Exon 6

Abstract

Familial hypocalciuric hypercalcemia (FHH) belongs to the disorders of a disturbed calcium homeostasis. Genetically, the disorder is inherited in an autosomal-dominant trait and represents an inactivating mutation of the calcium sensing receptor (CaSR) gene. We identified a Franconian kindred in which 6 individuals could be tested by molecular genetic means. In 5 individuals of 3 generations, the mutation could be classified as c.1697_1698delTG. This novel germline mutation creates a premature stop codon leading to a loss of 510 amino acids of the protein. The detection of CaSR gene mutations is suitable to differentiate states of hypercalcemia and may help to avoid invasive procedures such as parathyroidectomies.

Key words

calcium sensing receptor - inactivating gene mutations - hypercalcemia - familial hypocalciuric hypercalcemia

• References

• 1 Nesbit MA, Hannan FM, Howles SA, Babinsky VN, Head RA, Cranston T, Rust N, Hobbs MR, Heath 3rd H, Thakker RV. Mutations affecting G-protein subunit α11 in hypercalcemia and hypocalcemia. N Engl J Med 2013; 368: 2476-2486
• 2 Aida K, Kioshi S, Inoue M, Nakazato M, Tawata M, Onaya T. Familial hypocalciuric hypercalcemia associated with mutation in the human Ca(2+)-sensing receptor gene. J Clin Endocrinol Metab 1995; 80: 2594-2598
• 3 Christensen SE, Nissen PH, Vestergaard P, Mosekilde L. Familial hypocalciuric hypercalcemia: a review. Curr Opin Endocrinol Diabetes Obes 2011; 18: 359-370
• 4 UniProtKB : Extracellular calcium-sensing receptor http://www.uniprot.org/uniprot/P41180
• 5 Alfadda TI, Saleh AMA, Houillier P, Geibel JP. Calcium-sensing receptor 20 years later. Am J Physiol Cell Physiol 2014; 307: C221-C231
• 6 Hinnie J, Bell E, McKillop E, Gallacher S. The prevalence of familial hypocalciuric hypercalcemia. Calcif Tissue Int 2001; 68: 216-218
• 7 Zofková I. Hypercalcemia. Pathophysiological aspects. Physiol Res 2016; 65: 1-10
• 8 Taki K, Kogai T, Sakumoto J, Namatame T, Hishinuma A. Familial hypocalciuric hypercalcemia with a de novo heterozygous mutation of calcium-sensing receptor. Endocronol Diabetes Metab Case Rep 2015; 150016 DOI: DOI: 10.1530/EDM-15-0016.
• 9 Mastromatteo E, Lamacchia O, Campo MR, Conserva A, Baorda F, Cinque L, Guarnieri V, Scillitani A, Cignarelli M. A novel mutation in calcium-sensing receptor gene associated to hypercalcemia and hypercalciuria. BMC Endocr Disord 2014; 14: 1-6
• 10 Frank-Raue K, Leidig-Bruckner G, Haag C, Schulze E, Lorenz A, Schmitz-Winnenthal H, Raue F. Inactivating calcium-sensing receptor mutations in patients with primary hyperparathyroidism. Clin Endocrinol 2011; 75: 50-55
• 11 Marx SJ, Attie MF, Levine MA, Spiegel AM, Downs Jr RW, Lasker RD. The hypocalciuric or benign variant of familial hypercalcemia: clinical and biochemical features in fifteen kindreds. Medicine 1981; 60: 397-412
• 12 Law Jr. WM, Heath 3rd H. Familial benign hypercalcemia (hypocalciuric hypercalcemia). Clinical and pathogenetic studies in 21 families. Ann Intern Med 1985; 102: 511-519
• 13 Hannan FM, Thakker RV. Calcium-Sensing receptor (CaSR) mutations and disorders of calcium, electrolyte and water metabolism. Best Pract Res Clin Endocrinol Metab 2013; 27: 359-371
• 14 Ward DT, Mughal MZ, Ranieri M, Dvorak-Ewell MM, Valenti G, Riccardi D. Molecular and clinical analysis of a neonatal severe hyperparathyroidism case caused by a stop mutation in the calcium-sensing receptor extracellular domain representing in effect a human ,,knockout”. Eur J Endocrinol 2013; 169: K1-K7
• 15 Ogino S, Gulley ML, den Dunnen JT, Wilson RB. Association for Molecular Pathology Training and Education Committee. Standard mutation nomenclature in molecular diagnostics. Practical and educational challenges. J Mol Diagn 2007; 9: 1-6
• 16 Hendy GN, Guarnieri V, Canaff L. Calcium-sensing receptor and associated diseases. Prog Mol Biol Transl Sci 2009; 89: 31-95
• 17 CASRdb Calcium-Sensing Receptor Database www.casrdb.mcgill.ca
• 18 Thakker RV. Diseases associated with the extracellular calcium-sensing receptor. Cell Calcium 2004; 35: 275-282
• 19 Cole DEC, Yun FHJ, Wong BYL, Shuen AY, Booth RA, Scillitani A, Pidasheva S, Zhou X, Canaff L, Hendy GN. Calcium-sensing receptor mutations and denaturing high performance liquid chromatography. J Mol Endocrinol 2009; 42: 331-339
• 20 Falchetti A, Gozzini A, Terranegra A, Soldati L, Vezzoli G, Leoncini G, Giusti F, Franceschelli F, Masi L, Tanini A, Cavalli L, Brandi ML. A novel germline inactivating mutation in the CASR gene in an Italian kindred affected by familial hypocalciuric hypercalcemia. Eur J Endocrinol 2012; 166: 933-940
• 21 Garrett JE, Capuano IV, Hammerland LG, Hung BCP, Brown EM, Hebert SC, Nemeth EF, Fuller F. Molecular cloning and functional expression of human parathyroid calcium receptor cDNAs. J Biol Chem 1995; 270: 12919-12925
• 22 Stratta P, Merlotti G, Musetti C, Quaglia M, Pagani A, Izzo C, Radin E, Airoldi A, Baorda F, Palladino T, Leone MP, Guarnieri V. Calcium-sensing-related gene mutations in hypercalcaemic hypocalciuric patients as differential diagnosis from primary hyperparathyroidism: detection of two novel inactivating mutations in an Italian population. Nephrol Dial Transplant 2014; 29: 1902-1909
• 23 Ward BK, Magno AL, Blitvich BJ, Rea AJ, Stuckey BG, Walsh JP, Ratajczak T. Novel mutations in the calcium-sensing receptor gene associated with biochemical and functional differences in familial hypocalciuric hypercalcaemia. Clin Endocrinol 2006; 64: 580-587
• 24 Valcour A, Blocki F, Hawkins DM, Rao SD. Effects of age and serum 25-OH-vitamin D on serum parathyroid hormone levels. J Clin Endocrinol Metab 2012; 97: 3989-3995